Evidence map›Paper›PMID 36230441›Full record

ArticleAnimals : an open access journal from MDPI2022

Effectiveness of an

Victoriano Corpas-López, Victoriano Díaz-Sáez, Francisco Morillas-Márquez, Francisco Franco-Montalbán, Mónica Díaz-Gavilán, Julián López-Viota, Margarita López-Viota, José Antonio Gómez-Vidal, Joaquina Martín-Sánchez

Open access · goldAbstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 4 citations in OpenAlex.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Victoriano Corpas-LópezDepartamento de Parasitología, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.ORCID 0000-0001-9152-6486
Victoriano Díaz-SáezDepartamento de Parasitología, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.
Francisco Morillas-MárquezDepartamento de Parasitología, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.
Francisco Franco-MontalbánDepartamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.ORCID 0000-0001-6539-1653
Mónica Díaz-GavilánDepartamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.ORCID 0000-0002-7868-7231
Julián López-ViotaDepartamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.
Margarita López-ViotaDepartamento de Farmacia y Tecnología Farmacéutica, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.
José Antonio Gómez-VidalDepartamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.ORCID 0000-0003-0937-698X
Joaquina Martín-SánchezDepartamento de Parasitología, Facultad de Farmacia, Universidad de Granada, 18011 Granada, Spain.ORCID 0000-0003-3981-9227
Universidad de Granada · ES

Funding

Regional Government of Andalusia B-CTS-270-UGR18Regional Government of Andalusia P20_00130
6 · The paper itself

Abstract

Canine leishmaniosis is a challenge in veterinary medicine and no drug to date has achieved parasite clearance in dogs. Histone deacetylase inhibitors are a drug class widely used in cancer chemotherapy. We have successfully used

Indexed as

canine leishmaniosiseffectivenesshistone deacetylase inhibitorsO-alkyl hydroxamatessafetytreatmentvorinostat derivatives

Identifiers

PMID36230441
PMCPMC9559384
OpenAlexW4303579006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.